GS
The Goldman Sachs Group, Inc.
GS's fundamentals are strong: revenue grew 19% and its operating margin rose 4 points to 40%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
PSBD
Palmer Square Capital BDC Inc.
There isn't enough reported data to score PSBD yet.
GS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
GS's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like GS.
PSBD Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| N/A | |
| N/A |
PSBD's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like PSBD.
GS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.6x | $528 | -42% |
| Current | 13x | $914 | โ |
| Forward | 13x | $914 | โ |
| Fair | 14x | $940 | +2.9% |
| Expensive | 17x | $1,214 | +33% |
Historical ranges are pointers, not guarantees.
GS's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
PSBD PE Valuation
PSBD has no meaningful PE right now: it lost money over the past year.
GS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
GS has the edge over PSBD on the outlook, with more favorable earnings and revenue expectations.
PSBD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect PSBD's earnings and profitability to decline, with its revenue holding steady.
GS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $72.35 | +4% |
| Q3 2026 | $69.58 | +41% |
| Q2 2026 | $64.82 | +43% |
| Q1 2026 | $54.75 | +27% |
| Q4 2025 | $51.32 | +27% |
| Q3 2025 | $49.22 | +44% |
| Q2 2025 | $45.37 | +45% |
| Q1 2025 | $43.08 | +68% |
| Q4 2024 | $40.54 | +77% |
GS has the stronger earnings trend. Trailing diluted EPS is up 41% for GS versus PSBD down 7.9%.
PSBD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.54 | -12% |
| Q3 2023 | $3.42 | +$5.65 |
| Q2 2023 | $1.91 | +$3.78 |
| Q1 2023 | -$1.06 | -431% |
| Q4 2022 | -$2.31 | -485% |
PSBD earned $1.76 per share over the past year, down 7.9% from the year before.
GS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +23% |
| Q2 2026 | $20.3B | +39% |
| Q1 2026 | $17.2B | +14% |
| Q4 2025 | $13.5B | -3% |
| Q3 2025 | $15.2B | +20% |
| Q2 2025 | $14.6B | +15% |
| Q1 2025 | $15.1B | +6% |
| Q4 2024 | $13.9B | +23% |
GS has the edge over PSBD in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +2 points |
| Q2 2026 | 42% | +8.1 points |
| Q1 2026 | 38% | +0.2 points |
| Q4 2025 | 44% | +5.6 points |
| Q3 2025 | 36% | +4.1 points |
| Q2 2025 | 34% | +3.2 points |
| Q1 2025 | 37% | +0.6 points |
| Q4 2024 | 38% | +18 points |
GS's operating margin was 37% last quarter, up 2 points from the same quarter a year ago.
PSBD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2022 | $765.3K | -89% |
| Q3 2021 | $7.2M | -59% |
| Q2 2021 | $7.4M | -78% |
PSBD's revenue has slid since its 2020 peak: $765,339 last quarter, down 89% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2022 | -883% | -948 points |
| Q4 2021 | 54% | -33 points |
| Q3 2021 | 66% | -29 points |
| Q2 2021 | 68% | N/A |
| Q1 2021 | 69% | N/A |
| Q3 2020 | 87% | N/A |
| Q2 2020 | 95% | N/A |
PSBD's operating margin was โ883% last quarter, down 952 points from the same quarter a year ago, near the bottom of its range since 2020.
GS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +72% |
| Q2 2026 | $5.6B | +7.8% |
| Q1 2026 | -$32.4B | +$5.3B |
| Q4 2025 | -$16.8B | -136% |
| Q3 2025 | $2.1B | +$40.6B |
| Q2 2025 | $5.2B | -6.8% |
| Q1 2025 | -$37.7B | -$9.2B |
| Q4 2024 | $46.2B | +$75.1B |
GS's free cash flow was โ$40B over the past year, against $15.8B the year before. Free cash flow isn't a meaningful measure for financial services companies like GS.
PSBD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $57.3M | +227% |
| Q2 2026 | $21.3M | -48% |
| Q1 2026 | $29.1M | -37% |
| Q4 2025 | $55.7M | +63% |
| Q3 2025 | $17.5M | +399% |
| Q2 2025 | $41M | +$41.5M |
| Q1 2025 | $46.4M | +$284.3M |
| Q4 2024 | $34.3M | +907% |
PSBD has the edge over GS on cash generation, producing positive trailing cash flow while its opponent burns cash.
GS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.4x | Net Cash |
| Q2 2026 | -6.1x | Net Cash |
| Q1 2026 | -6.7x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -3.1x | Net Cash |
| Q1 2025 | -3.9x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
GS has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like GS.
PSBD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2022 | 64.0x | High |
| Q4 2021 | 34.0x | High |
PSBD's net debt is more than 20 years of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like PSBD.
GS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 16.3 | Oversold |
GS's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).
PSBD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.7 | Neutral |
| Stochastic | 33.0 | Neutral |
PSBD's weekly RSI is 42 (neutral) and its Stochastic is 33 (neutral).
GS PE vs Financial Services Sector
| Metric | GS | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.8% above |
| PE % | 46 | 63 | 17 pts below |
GS is trading at 13x earnings, in line with the Financial Services sector's median of 13x, though its earnings don't support one.
PSBD PE vs Financial Services Sector
| Metric | PSBD | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | โ |
PSBD has no meaningful PE right now: it lost money over the past year.
GS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $895.5 | 2% above |
| 20 week MA | $977.4 | 6.5% below |
| 50 week MA | $945.4 | 3.4% below |
| 100 week MA | $804.5 | 14% above |
| 200 week MA | $602.7 | 52% above |
GS has stronger trend alignment. GS is above 3 of 5 weekly averages versus PSBD above 1 of 4.
PSBD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.78 | 0.5% above |
| 20 week MA | $10.0 | 1.8% below |
| 50 week MA | $10.7 | 7.8% below |
| 100 week MA | $12.3 | 20% below |
PSBD has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 20% below its 100-week average.
GS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $230.7 | $256.2 | +11% |
| 2021 | $256.2 | $385.0 | +50% |
| 2022 | $385.0 | $345.5 | -10% |
| 2023 | $345.5 | $385.8 | +12% |
| 2024 | $385.8 | $576.2 | +49% |
| 2025 | $576.2 | $907.0 | +57% |
| 2026 YTD | $907.0 | $913.6 | +0.7% |
GS has the edge over PSBD on returns for 2026, with the stronger performance.
PSBD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $16.4 | $15.5 | -5.3% |
| 2025 | $15.5 | $12.2 | -21% |
| 2026 YTD | $12.2 | $9.83 | -20% |
PSBD has finished every year since 2024 lower, and it's down 20% so far in 2026.